Frelii Releases Information Regarding Its Use Of Artificial...

Frelii provides a shareholder update on the company’s development of its technology licensing business model.(PRWeb December 03, 2018)Read the full story at https://www.prweb.com/releases/frelii_releases_information_regarding_its_use_of_artificial_intelligence_to_interpret_dna_testing_results/prweb15963027.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals